Author:
Esfahani Merat Karbasian,Morris Evelyn L.,Dutcher Janice P.,Wiernik Peter H.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Oncology
Reference60 articles.
1. Faderl S, Talpaz M, Estrov Z, et al.: Chronic myelogenous leukemia: biology and therapy. Ann Intern Med 1999, 131:207–219; and The biology of chronic myeloid leukemia. N Engl J Med 1999, 341:164. This study provides a useful overview of switching treatment of CML from chemotherapy to targeted therapy based on the biology of the disease.
2. Deininger MW, Goldman JM, Melo JV: The molecular biology of chronic myeloid leukemia. Blood 2000, 96:3343–3356.
3. Giles FJ, Cortes JE, Kantarjian HM, et al.: Accelerated and blastic phases of chronic myelogenous leukemia. Hematol Oncol Clin North Am 2004, 18:753–774.
4. Axdorph U, Stenke L, Grimfors G, et al.: Intensive chemotherapy in patients with chronic myelogenous leukemia (CML) in accelerated or blastic phase--a report from the Swedish CML group. Br J Haematol 2002, 118:1048–1054.
5. Bolaman Z, Koseoglu M, Ayyildiz O, et al.: Treatment of blastic phase chronic myeloid leukemia with mitox-antrone, cytosine arabinoside and high dose methyl-prednisolone. Hematologica 2002, 32:49–57.
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献